Who is the CEO of Antengene Corporation Limited?

Dr. Jay Mei is the Executive Chairman of the Board of Antengene Corporation Limited, joining the firm since 2018.

What is the price performance of ANTENGENE-B stock?

The current price of ANTENGENE-B is $4.39, it has decreased 0.45% in the last trading day.

What are the primary business themes or industries for Antengene Corporation Limited?

Antengene Corporation Limited belongs to Pharmaceuticals industry and the sector is Health Care

What is Antengene Corporation Limited market cap?

Antengene Corporation Limited's current market cap is $2.6B

Antengene Corporation Limited (06996.HK) Stock Price, Chart, News and AI analysis



06996.HK

ANTENGENE-B (06996.HK)

Antengene Corporation Limited

HK$4.39

-0.45%

$-0.02

CLOSED_MARKET: Jul 14, 16:00:00 HKT

Key Stats

Prev.Close

$4.41

Open

$4.45

Day's Range

$4.26 - $4.45

52 week range

$2.76 - $8.16

Volume

1.6M

Avg.Volume

1.7M

Dividend yield

EPS (TTM)

-0.44

Market Cap

$2.6B

What is ANTENGENE-B?

Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.

Features

Markets

News

Antengene Corporation Limited (06996.HK)

06996.HK Stock Price Chart